Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
04/2005
04/05/2005US6875779 Cyclooxygenase inhibitor
04/05/2005US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
04/05/2005US6875767 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors
04/05/2005US6875597 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems
04/05/2005US6875570 Proteins and nucleic acids encoding same
03/2005
03/31/2005WO2005028491A1 Epimeredi glycoside a, the formulation containing thereof and their preparation method
03/31/2005WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor
03/31/2005WO2005027889A1 Visceral pain dulling composition
03/31/2005WO2005007102A3 Phytochemicals for the treatment of mastalgia, endometriosis and hpv-related conditions including cervical dysplasia
03/31/2005WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/31/2005US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents
03/31/2005US20050070713 Neurokinin antagonist; therapy for central nervous system disorders; psychological disorders; Parkinson's and Huntington's disease
03/31/2005US20050070694 Antagonistic anti-htnfsf13b human antibodies
03/31/2005US20050070581 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
03/31/2005US20050070559 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
03/31/2005US20050070558 For example, [4-(2,4-Dioxo-1,3-dipropyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy]acetic acid; useful in preventing mast cell degranulation and therefore useful in treatment of diseases induced by activation of A2b receptor and mast cell activation such as asthma, allergic reactions
03/31/2005US20050070541 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis
03/31/2005US20050070534 Non-peptidic NPY Y2 receptor inhibitors
03/31/2005US20050070470 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
03/31/2005US20050070466 Diagnostic imaging agents; targeting vectors which bind to integrin receptors; bicyclic arginine-glycine-aspartic acid derivatives; stablility; reduced background interference
03/31/2005US20050069878 Proteins associated with cell growth, differentiation, and death
03/31/2005US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
03/31/2005US20050069598 Antidiabetic agents; moderate glucagon-like peptide; phosphoenolpyruvate carboxykinase inhbitors; weight control
03/31/2005US20050069577 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
03/31/2005US20050069547 Binding protein; therapy for bone tumors
03/31/2005US20050069537 Stimulants of survival of cells; binding of cellular adhesion molecular; prevent apoptosis
03/31/2005US20050069533 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof
03/31/2005US20050069276 Deuterated pyrazolopyrimidinones and drugs containing said compounds
03/30/2005EP1518864A2 Antibody against rhesus D
03/30/2005EP1517989A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
03/30/2005EP1517914A2 9-alpha-substituted estratrienes as selectively active estrogen
03/30/2005EP1517909A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
03/30/2005EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
03/30/2005EP1517889A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
03/30/2005EP1517672A1 Compositions and methods for amelioration of human female sexual dysfunction
03/30/2005EP1517667A2 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
03/30/2005EP1438289B1 Indole derivatives as cox ii inhibitors
03/30/2005EP1390025B1 Use of coenzyme q (ubiquinone) and eicosapentaenoic acid (epa) for the treatment of non-hodgkin's lymphoma and psychiatric or neurological disorders
03/30/2005EP1194429B1 Potassium channel openers
03/30/2005EP1185294B1 Peptides for the treatment of impaired interpersonal and behavioral disorders
03/30/2005EP1091942B1 Potassium channel blocking agents
03/30/2005EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders
03/30/2005EP0876610A4 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility
03/30/2005CN1602317A Angiopoietin-2 specific binding agents
03/30/2005CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents
03/30/2005CN1602304A Deuterated substituted dihydrofuranones and medicaments containing these compounds
03/30/2005CN1602189A Composition comprising cysteamine for improving lactation in dairy animals
03/30/2005CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution
03/30/2005CN1600370A New chemical medicine in small molecule in use for curing dysmenorrhea and ache of bad rheumatoid arthritis
03/30/2005CN1600360A Soft capsule of decoction of four ingredients possessing effect of enriching blood and regulating menstruation and preparation method
03/30/2005CN1600347A Chinese traditional medicine for curing dysmenorrhea
03/30/2005CN1600338A Medication for treating syndrome after childbirth
03/30/2005CN1600325A Capsule
03/30/2005CN1600315A Soft capsule combination of Cloquinate/Promestriene in use for vagina
03/30/2005CN1194758C Vaginal lactobacillus medicant
03/30/2005CN1194756C Oral Chinese medicinal contraceptive medicine
03/30/2005CN1194749C Medicine for treating functional metrorrhagia and preparing process thereof
03/30/2005CN1194737C Chinese patent drug for preventing miscarriage and promoting health growth of fetus and process for preparing same
03/30/2005CN1194735C Chinese medicine for treating hyperplasia of mammary glands
03/30/2005CN1194713C Medicine for resisting senility, shrinking vagina, beautifying breast and stregthening male genitals and its production method
03/30/2005CN1194701C Application of icaritin or demethylicaritin in preparing estrogen receptor moderator
03/30/2005CN1194689C Tetrahydropalmatine dispersion tablet for treating menalgia, and its prep no method
03/29/2005US6872853 Bioavailability; reacting sertratineamine with hydrogen chloride
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872749 Administering to the cow salt of ester of methionine, an ester of methionine amide, and an ester of the hydroxy analogue of methionine
03/29/2005US6872746 Isomeric fused pyrrolocarbazoles and isoindolones
03/29/2005US6872744 Analgesics
03/29/2005US6872731 Imidazo-pyridine derivatives as ligands for GABA receptors
03/29/2005US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/29/2005US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione
03/29/2005US6872709 Using glycyrrhizin
03/29/2005CA2280447C Pyrrolo¬1,2-a|pyrazine derivatives as 5ht1a ligands
03/29/2005CA2268870C Heterocyclic carboxamides
03/29/2005CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2195745C Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
03/24/2005WO2005025588A1 Extract of ogalpi, erectile dysfunction fanning healthy food and erectile dysfunction treating agent containing the same
03/24/2005WO2005025550A1 Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
03/24/2005WO2005025503A2 A composition and method of treatment for urogenital conditions
03/24/2005WO2005025356A2 Orthopedic insoles for protecting skin from stretching and cracking in the area of the five metatarsal heads of the forefoot
03/24/2005WO2002092759A9 Molecules for disease detection and treatment
03/24/2005US20050065179 Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments
03/24/2005US20050065170 Compounds
03/24/2005US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
03/24/2005US20050065159 Penis enlargement
03/24/2005US20050065140 Antidepressant; side effect reduction
03/24/2005US20050065135 Contraceptives; side effect reduction; antitumor, anticancer agents
03/24/2005US20050065080 Use of leptin in fertility
03/24/2005US20050065069 Use of hcg in controlled ovarian hyperstimulation
03/24/2005US20050064522 EG-VEGF nucleic acids and polypeptides and methods of use
03/24/2005US20050064031 Combination contraceptive, kits that contain the latter, and a method that uses the latter
03/24/2005CA2542303A1 A composition and method of treatment for urogenital conditions
03/24/2005CA2538997A1 Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
03/23/2005EP1516871A1 Benzoindoline derivatives with adrenergic activity
03/23/2005EP1516621A2 Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases
03/23/2005EP1516064A2 Methods of using 46828, a human acyl-coa synthetase
03/23/2005EP1516047A1 Purified pkb ser 473 kinase and uses thereof
03/23/2005EP1515978A1 Sulfur-containing phospholipid derivatives
03/23/2005EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/23/2005EP1515961A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction